Table 2 from The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients
收藏数据链接：
官方服务：
资源简介：
Overview of WBHT session completion per patient, including details on nonadherence and discontinuation from the MATTERS study.
创建时间：
2026-02-04
